Olga V. Saik

Olga V. Saik

Auto-generated profile, based on publicly available information

Olga V. Saik

Federal Research Center Institute of Cytology and Genetics

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2014 in NMR in Biomedicine
Verified
Journal Article
Closed access
PDF file
MMMikhail Pavlovich Moshkin
Mikhail Pavlovich Moshkin
AAAndrey Akulov
Andrey Akulov
DPDmitriy V. Petrovski
Dmitriy V. Petrovski
OSOlga V. Saik
Olga V. Saik
EPEvgeny D. Petrovskiy
Evgeny D. Petrovskiy
IKIgor V. Koptyug
Igor V. Koptyug

14 July 2021 in Diabetes mellitus
Verified
Journal Article
Open access
PDF file
Vadim V. KlimontovVadim V. Klimontov
Vadim V. Klimontov
VBVladimir Berikov
Vladimir Berikov
OSO. V. Saik
O. V. Saik
This review presents the applications of artificial intelligence for the study of the mechanisms of diabetes development and generation of new technologies of its prevention, monitoring and treatment. In recent years, a huge amount of molecular data has been accumulated, revealing the pathogenic mechanisms of diabetes and its complications. Data mining and text mining open up new possibilities for processing this information. Analysis of gene networks makes it possible to identify molecular interactions that are important for the development of diabetes and its complications, as well as to identify new targeted molecules. Based on the big data analysis and machine learning, new platforms have been created for prediction and screening of diabetes, diabetic retinopathy, chronic kidney disease, and cardiovascular disease. Machine learning algorithms are applied for personalized prediction of glucose trends, in the closed-loop insulin delivery systems and decision support systems for lifestyle modification and diabetes treatment. The use of artificial intelligence for the analysis of large databases, registers, and real-world evidence studies seems to be promising. The introduction of artificial intelligence systems is in line with global trends in modern medicine, including the transition to digital and distant technologies, personification of treatment, high-precision forecasting and patient-centered care. There is an urgent need for further research in this field, with an assessment of the clinical effectiveness and economic feasibility.